Definitive Healthcare (DH) Stock: Buy, Sell, or Hold?
DH - Definitive Healthcare Corp. Class A Common Stock
$0.94
0.03 (3.44%)
â˛
5d:
-7.32%
30d:
+3.75%
90d:
+20.06%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When DH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: DH is fairly priced but lacks strong directional signals. At -5.6% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: DH is fairly priced but lacks strong directional signals. At -5.6% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: DH is currently trading at $0.94, which is considered fair relative to its 30-day fair value range of $0.85 to $1.03. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.0) compared to its historical average (6.0). Remarkably, the market is currently pricing in an annual earnings decline of 5.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, DH is showing sideways momentum. Immediate support is located at $0.89, while resistance sits at $1.03. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: DH scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $1.90 (+103.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DH is showing sideways momentum. Immediate support is located at $0.89, while resistance sits at $1.03. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: DH scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $1.90 (+103.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.85 -
$1.03
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
88.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.4%)
- BULLISH: Trading 103.0% below Wall St target ($1.90)
- WARNING: Composite score 53/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.85 -
$1.03
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.89
Resistance Level
$1.03
Current Trend
Sideways
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
5.02
Wall Street Target
$1.90
(+103.0%)
Revenue Growth (YoY)
-9.1%
Profit Margin
-72.3%
Valuation Discount vs History
-5.6% cheaper
PE vs Historical
5.0 vs 6.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.6%
(market-implied from PE analysis)
1-Year Target
$0.88
(-6%)
2-Year Target
$0.83
(-11%)
3-Year Target
$0.79
(-16%)
3-Yr Target (if PE normalizes)
(PE: 5â6)
$0.94
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: -4.2%)
$3.35
(+258%)
Base:
(SPY PE: 5.0, Growth: -4.2%)
$0.82
(-12%)
Bear:
(PE: 4.3, Growth: -4.2%)
$0.70
(-25%)
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.0 to 6.0
Stabilization Target:
$1.12
(+19.6%)
PE Expansion Potential:
+19.6%
Share & Embed Analysis
Last updated: October 01, 2026 5:39 PM ET
Data refreshes hourly during market hours. Next update: 6:39 PM
Data refreshes hourly during market hours. Next update: 6:39 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 60 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 80 BUY |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$297 | 41 HOLD |
|
GEHC
GE HealthCare TechnologiâĻ |
STRONG BUY
21 analysts |
$90 | 56 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 51 HOLD |
